These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3525224)

  • 1. Inhibition of fungal and mammalian sterol biosynthesis by 2-aza-2,3-dihydrosqualene.
    Ryder NS; Dupont MC; Frank I
    FEBS Lett; 1986 Aug; 204(2):239-42. PubMed ID: 3525224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of sterol biosynthesis in Saccharomyces cerevisiae and Candida albicans by 22,23-epoxy-2-aza-2,3-dihydrosqualene and the corresponding N-oxide.
    Balliano G; Milla P; Ceruti M; Carrano L; Viola F; Brusa P; Cattel L
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1904-8. PubMed ID: 7810997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential inhibition of fungal oxidosqualene cyclase by 6E and 6Z isomers of 2,3-epoxy-10-aza-10,11-dihydrosqualene.
    Balliano G; Milla P; Ceruti M; Viola F; Carrano L; Cattel L
    FEBS Lett; 1993 Apr; 320(3):203-6. PubMed ID: 8462686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2,3-Epoxy-10-aza-10,11-dihydrosqualene, a high-energy intermediate analogue inhibitor of 2,3-oxidosqualene cyclase.
    Ceruti M; Balliano G; Viola F; Grosa G; Rocco F; Cattel L
    J Med Chem; 1992 Aug; 35(16):3050-8. PubMed ID: 1501233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 22,23-Epoxy-2-aza-2,3-dihydrosqualene derivatives: potent new inhibitors of squalene 2,3-oxide-lanosterol cyclase.
    Viola F; Ceruti M; Balliano G; Caputo O; Cattel L
    Farmaco; 1990 Sep; 45(9):965-78. PubMed ID: 2282128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cholesterol biosynthesis in 3T3 fibroblasts by 2-aza-2,3-dihydrosqualene, a rationally designed 2,3-oxidosqualene cyclase inhibitor.
    Gerst N; Schuber F; Viola F; Cattel L
    Biochem Pharmacol; 1986 Dec; 35(23):4243-50. PubMed ID: 3790151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of 2,3-oxidosqualene cyclase and sterol biosynthesis by 10- and 19-azasqualene derivatives.
    Viola F; Brusa P; Balliano G; Ceruti M; Boutaud O; Schuber F; Cattel L
    Biochem Pharmacol; 1995 Sep; 50(6):787-96. PubMed ID: 7575639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 2,3-oxidosqualene-lanosterol cyclase in Candida albicans by pyridinium ion-based inhibitors.
    Goldman RC; Zakula D; Capobianco JO; Sharpe BA; Griffin JH
    Antimicrob Agents Chemother; 1996 Apr; 40(4):1044-7. PubMed ID: 8849227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug design based on biosynthetic studies: synthesis, biological activity, and kinetics of new inhibitors of 2,3-oxidosqualene cyclase and squalene epoxidase.
    Cattel L; Ceruti M; Balliano G; Viola F; Grosa G; Schuber F
    Steroids; 1989; 53(3-5):363-91. PubMed ID: 2678608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ergosterol biosynthesis inhibition by the thiocarbamate antifungal agents tolnaftate and tolciclate.
    Ryder NS; Frank I; Dupont MC
    Antimicrob Agents Chemother; 1986 May; 29(5):858-60. PubMed ID: 3524433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Squalene analogues containing isopropylidene mimics as potential inhibitors of pig liver squalene epoxidase and oxidosqualene cyclase.
    Sen SE; Prestwich GD
    J Med Chem; 1989 Sep; 32(9):2152-8. PubMed ID: 2769687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation and activation of various membranal enzymes of the cholesterol biosynthetic pathway by digitonin.
    Eilenberg H; Klinger E; Przedecki F; Shechter I
    J Lipid Res; 1989 Aug; 30(8):1127-35. PubMed ID: 2504860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of squalene epoxidase inhibitors on Candida albicans.
    Georgopapadakou NH; Bertasso A
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1779-81. PubMed ID: 1416865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terbinafine: mode of action and properties of the squalene epoxidase inhibition.
    Ryder NS
    Br J Dermatol; 1992 Feb; 126 Suppl 39():2-7. PubMed ID: 1543672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antifungal agents on ergosterol biosynthesis in Candida albicans and Trichophyton mentagrophytes: differential inhibitory sites of naphthiomate and miconazole.
    Morita T; Nozawa Y
    J Invest Dermatol; 1985 Nov; 85(5):434-7. PubMed ID: 3902987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of a particulate squalene epoxidase from Candida albicans.
    Ryder NS; Dupont MC
    Biochim Biophys Acta; 1984 Jul; 794(3):466-71. PubMed ID: 6378256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro inhibition of animal and higher plants 2,3-oxidosqualene-sterol cyclases by 2-aza-2,3-dihydrosqualene and derivatives, and by other ammonium-containing molecules.
    Duriatti A; Bouvier-Nave P; Benveniste P; Schuber F; Delprino L; Balliano G; Cattel L
    Biochem Pharmacol; 1985 Aug; 34(15):2765-77. PubMed ID: 4015713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and inhibition studies of sulfur-substituted squalene oxide analogues as mechanism-based inhibitors of 2,3-oxidosqualene-lanosterol cyclase.
    Stach D; Zheng YF; Perez AL; Oehlschlager AC; Abe I; Prestwich GD; Hartman PG
    J Med Chem; 1997 Jan; 40(2):201-9. PubMed ID: 9003518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of squalene epoxidase by allylamine antimycotic compounds. A comparative study of the fungal and mammalian enzymes.
    Ryder NS; Dupont MC
    Biochem J; 1985 Sep; 230(3):765-70. PubMed ID: 3877503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A non-azole inhibitor of lanosterol 14 alpha-methyl demethylase in Candida albicans.
    Capobianco JO; Doran CC; Goldman RC; De B
    J Antimicrob Chemother; 1992 Dec; 30(6):781-90. PubMed ID: 1289352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.